Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 4, 2009, Pages 247-252

  Madden, J ^a   Shearman, C P ^a   Dunn, R L ^a   Dastur, N D ^a   Tan, R M ^a   Nash, G B ^b   Rainger, G Ed ^b   Brunner, A ^a   Calder, P C ^a   Grimble, R F ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CD44; CD44v3; Omega 3 fatty acids; Peripheral arterial disease (PAD)

Indexed keywords

CD44 PROTEIN, HUMAN; DOCOSAHEXAENOIC ACID; HERMES ANTIGEN; ICOSAPENTAENOIC ACID; ISOPROTEIN;

AGED; ARTICLE; BLOOD; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; MALE; MICROCAPSULE; MIDDLE AGED; MONOCYTE; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CAPSULES; CELLS, CULTURED; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PERIPHERAL VASCULAR DISEASES; PROTEIN ISOFORMS; TREATMENT OUTCOME;

EID: 67349283021     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.06.011     Document Type: Article

References (30)

1. Leng G.C., Lee A.J., Fowkes F.G., Whiteman M., Dunbar J., Housley E., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25 (1996) 1172-1181
2. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Lesley J., and Hyman R. CD44 structure and function. Front Biosci 3 (1998) d616-d630
4. DeGrendele H.C., Estess P., Picker L.J., and Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183 (1996) 1119-1130
5. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21 (2002) 25-29
6. Fitzgerald K.A., and O'Neill L.A. Characterization of CD44 induction by IL-1: a critical role for Egr-1. J Immunol 162 (1999) 4920-4927
7. Gee K., Kryworuchko M., and Kumar A. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases. Arch Immunol Ther Exp (Warsz) 52 (2004) 13-26
8. Haynes B.F., Hale L.P., Patton K.L., Martin M.E., and McCallum R.M. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum 34 (1991) 1434-1443
9. Cuff C.A., Kothapalli D., Azonobi I., Chun S., Zhang Y., Belkin R., et al. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 108 (2001) 1031-1040
10. Lesley J., Hyman R., and Kincade P.W. CD44 and its interaction with extracellular matrix. Adv Immunol 54 (1993) 271-335
11. Rosenberg W.M., Prince C., Kaklamanis L., Fox S.B., Jackson D.G., Simmons D.L., et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345 (1995) 1205-1209
12. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83 (2006) 1505S-1519S
13. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
14. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 (2000) S21-S27
15. Leir SHICAM-1 and CD44 expression in human bronchial epithelium and the role of CD44 isoforms in cell adhesion, migration and repair. PhD thesis; Southampton University 2002.
16. Krettek A., Sukhova G.K., Schonbeck U., and Libby P. Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm. Am J Pathol 165 (2004) 1571-1581
17. de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., and Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163 (2003) 121-133
18. Fieber C., Baumann P., Vallon R., Termeer C., Simon J.C., Hofmann M., et al. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 117 (2004) 359-367
19. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279 (2004) 17079-17084
20. Kremer J.M., Lawrence D.A., Petrillo G.F., Litts L.L., and Mullaly P.M. Arthritis Rheum 38 (1995) 1107-1114
21. Lepperdinger G., Mullegger J., and Kreil G. Hyal2 - less active, but more versatile?. Matrix Biol 20 (2001) 509-514
22. Rider C.C. Heparin/heperan sulphate binding in the TGF-beta cytokine superfamily. Biochem Soc Trans 34 (2006) 458-460
23. Pellegrini L. Role of heparin sulphate in fibroblast growth factor signalling: a structural view. Curr Opin Struct Biol 11 (2001) 629-634
24. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
25. Wibulswas A., Croft D., Pitsillides A.A., Bacarese-Hamilton I., McIntyre P., Genot E., et al. Influence of epitopes CD44v3 and CD44v6 in the invasive behaviour of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. Arthritis Rheum 46 (2002) 2059-2064
26. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 (1999) 319-328
27. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Pure E., et al. Resolution of lung inflammation by CD44. Science 296 (2002) 155-158
28. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
29. Macdonald D.C., Leir S.H., Brooks C., Sanders E., Lackie P., and Rosenberg W. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines. Eur J Gastroenterol Hepatol 15 (2003) 1101-1110
30. Grimble R.F., Howell W.M., O'Reilly G., Turner S.J., Markovic O., Hirrell S., et al. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr 76 (2002) 454-459